All In MedTech

Device Trial Radar · NCT05534477

Verily Clinical Study Watch Analytical Validation Study

Last checked: Nov 20, 2026Latest source record: Apr 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 18, 2023

Primary completion

Jun 2025

Study completion Jun 2025

Sponsor

Lead sponsor
Verily Life Sciences LLCNot on our public-company list
Sponsor type
Industry
First posted
Sep 9, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the performance of the Verily Clinical Study Watch for the quantification of participants' movement and pulse rate when the wearer is at rest.

Conditions

  • Healthy Population
  • Chronic Disease

Interventions

  • Verily Clinical Study WatchDevice

    The Study Watch is an investigational wrist worn wearable device made with biocompatible contact materials containing various sensors capable of continuous recording of physiological, activity, and environmental data.

  • Vivalink ECG PatchDevice

    The Vivalink ECG Patch is a continuously recording ECG monitor and will be used as a reference device for measuring participants' pulse rate, pulse rate variability, and pulse rate coverage. The Vivalink ECG Patch is a medical device manufactured by VivaLNK Inc. and has been cleared by the FDA.

  • Modus StepWatch 4Device

    Modus StepWatch 4 is an ankle-worn wearable medical device, and will be used as a reference device for measuring participants' ambulatory time and daily step count. The Modus StepWatch 4 is FDA listed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Accuracy of pulse rate when wearer is at restTime frame: Approximately 14-day at-home observational period with two virtual visits, one at the beginning and the other at the end of the at-home period.

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Verily Life Sciences

    South San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.